MapmyGenome™ Receives NABL Accreditation Setting Standards in Genetic Testing

MapmyGenome™ Receives NABL Accreditation Setting Standards in Genetic Testing

Hyderabad, January 11, 2023 – Mapmygenome, a leading provider of personalized health and wellness solutions through genomic tests, proudly announces its accreditation by the National Accreditation Board for Testing and Calibration Laboratories (NABL). This significant achievement underscores Mapmygenome's unwavering commitment to delivering high-quality and reliable services to its consumers.

The NABL accreditation is a rigorous process that evaluates laboratories based on their technical competence, quality management systems, and adherence to international standards. Earning this accreditation demonstrates MapmyGenome's dedication to maintaining the highest levels of accuracy, reliability, and efficiency in every aspect of its operations, from sample handling and analysis to data interpretation and reporting.

"At MapmyGenome™, we have always prioritized the delivery of accurate and actionable genetic information to empower individuals in managing their health and well-being," said Anu Acharya, CEO and Founder of  MapmyGenome. "Obtaining NABL accreditation is a significant milestone for us, as it reflects our commitment to the highest standards of quality and reliability in genetic testing. This achievement further strengthens our position as a trusted partner in personalized healthcare."

NABL accreditation not only validates the technical competence of Mapmygenome but also enhances the confidence of healthcare professionals, patients, and partners in the accuracy of the company's genetic testing services. The accreditation is a recognition of Mapmygenome's dedication to continuous improvement and its pursuit of excellence in preventive and clinical genomics tests.

About MapmyGenome

MapmyGenome™ uses genomics to personalize health and well-being. Our at-home DNA tests and diagnostic genomic tests provide DNA-based insights that enable consumers, physicians, and health service providers to create a personalized health journey. Established in 2013, MapmyGenome™ has a vision to “Touch 100 million lives and save a million lives by 2030. 

Some of the preventive genomic tests that Mapmygenome™ offers are Genomepatri™, BeautyMap™, MyFitGene™, Cardiomap™, MedicaMap™, and MapmyBiome™. MapMyGenome also helps people discover their ethnic roots with Genomepatri Heritage™.  

MapmyGenome’s clinical genomic tests include a comprehensive suite of solutions in reproductive health(BabyMap), cancer care(OncoMap), inherited rare diseases (RareMap), and organ health (BodyMap).

Leave a comment

Please note, comments need to be approved before they are published.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.